Location History:
- Leiden, NL (2019 - 2021)
- Oegstgeest, NL (2020 - 2022)
Company Filing History:
Years Active: 2019-2022
Title: The Innovations of Marko Potman
Introduction
Marko Potman is a notable inventor based in Oegstgeest, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of therapies for genetic disorders. With a total of 4 patents to his name, Potman is recognized for his innovative approaches to medical treatments.
Latest Patents
Among his latest patents, Potman has developed oligonucleotides that match COL7A1 exon 73 for the therapy of epidermolysis bullosa. These antisense oligonucleotides are designed to prevent or reduce the inclusion of exon 73 into human COL7A mRNA. The oligonucleotides are characterized by specific features, including a sequence that contains at most two CpG sequences, a length of no more than 24 nucleotides, and the ability to anneal to the (SRp40/SC35 binding/ESE) element in exon 73. Additionally, he has created antisense oligonucleotides aimed at treating dystrophic epidermolysis bullosa, which are capable of preventing or reducing exon 80 inclusion into human COL7A1 mRNA.
Career Highlights
Marko Potman is currently associated with Wings Therapeutics, Inc., where he continues to push the boundaries of medical research and innovation. His work focuses on developing cutting-edge therapies that address critical health issues.
Collaborations
Potman collaborates with esteemed colleagues such as Elisabeth Marlene Haisma and Gerardus Johannes Platenburg. These partnerships enhance the research and development efforts at Wings Therapeutics, Inc.
Conclusion
Marko Potman exemplifies the spirit of innovation in biotechnology through his groundbreaking patents and collaborative efforts. His work has the potential to significantly impact the treatment of genetic disorders, showcasing the importance of research and development in the medical field.